How much does Owkin AI cost?

Owkin AI operates on an enterprise pricing model, with no specific costs publicly listed. Interested pharmaceutical teams and researchers can book a demo to discuss their specific needs and obtain pricing information.

What can Owkin AI do?

Owkin AI's K Pro platform can perform rapid scientific literature reviews, consolidate knowledge from multiple sources, assist with smart hypothesis testing, provide scientific writing assistance, and create interactive data visualizations for complex patient datasets. It also offers AI diagnostics products.

Is Owkin AI suitable for small research teams?

Owkin AI offers a 'K Pro Free' version for researchers and academics, suggesting it can be used by smaller teams or individuals in academic settings. The advanced 'K Pro' version is designed for pharmaceutical teams with enhanced capabilities.

Does Owkin AI have an API?

Yes, Owkin AI provides documentation for integrating data into K Pro, which implies API availability for programmatic access and data exchange.

Launching soon — get early access:

AI Tools

Q: What is Owkin AI?

Owkin AI is an AI biotech company that develops agentic AI platforms, such as K Pro, to accelerate drug discovery, development, and diagnostics by processing complex patient data and discovering new biology.

Owkin AI - AI for Drug Discovery & Diagnostics | Intelloro | Intelloro

Quick Answer

Owkin AI is an AI biotech platform that uses agentic AI, like K Pro, to transform drug discovery, development, and diagnostics. It provides capabilities such as literature review, hypothesis testing, and data visualization, leveraging vast patient data networks. Best for pharmaceutical companies, biotech firms, and clinical researchers seeking to accelerate R&D and improve patient outcomes. Enterprise pricing; demo available.

About Owkin AI

Owkin is an AI biotech company that develops agentic AI platforms like K Pro to accelerate drug discovery, development, and diagnostics in healthcare. It processes complex patient data, identifies new drug candidates, and de-risks clinical trials. Owkin's AI is validated in real-world patients, continuously learning to refine predictions and accelerate decisions for pharmaceutical teams and researchers. Pricing is enterprise-focused.

What Makes It Unique

K Pro, an AI agent driving insight generation and decision making across drug discovery and development, continuously learns from real-world data, user feedback, and clinical validation, evolving toward fully automated R&D.

AI-extracted from public sources. May contain errors. Methodology · Are you Owkin AI? Claim listing

Use Cases & Target Users

Use Cases

Data Analysis

Best For

Accelerating drug discovery for pharmaceutical companies

De-risking and accelerating clinical trials for biotech firms

Improving patient diagnostics for clinicians and laboratories

Conducting comprehensive scientific literature reviews for researchers

Fit Score

Complexity

Advanced

Target Team Size

SMALL_TEAM

LARGE_TEAM

Target Skill Level

EXPERT

Key Features

AI-powered drug discovery

AI-powered drug development and clinical trial acceleration

AI diagnostics for oncology (MSIntuit® CRC, RlapsRisk® BC, TLS Detect)

Agentic AI platform (K Pro) for biological research

Rapid scientific literature review and gap analysis

Consolidated knowledge from multiple biomedical sources (e.g., PubMed)

Technical Specifications

API Available

SDK Available

MCP Compatible

Open Source

Team Features

SSO/Enterprise

Compliance, Privacy & Trust

GDPR (as claimed): Yes

SOC 2 (as claimed): No

HIPAA (as claimed): No

Trains on user data: No

Pros

+Leverages advanced agentic AI and biological reasoning models for complex R&D.
+Integrates over 22 million scientific article abstracts from PubMed for evidence-based insights.
+Offers clinically validated AI diagnostic tests like MSIntuit® CRC and RlapsRisk® BC.
+Backed by significant funding ($304M) from leading biopharma and venture funds.
+Strategic deals with top biopharmas including Sanofi, BMS, and MSD.
+Provides interactive data visualization for complex patient datasets (TCGA, MOSAIC).

Limitations

-No explicit pricing details available, likely high cost for enterprise clients.
-Requires access to and integration of complex patient data, which can be challenging.
-Focuses exclusively on the healthcare and life sciences industry.
-No mention of self-service or small-scale use cases.
-Limited public information on specific AI models used.

Base Models

OwkinZero

Uses Models

OwkinZero

Decision Intelligence

Best For

Accelerating drug discovery for pharmaceutical companies

De-risking and accelerating clinical trials for biotech firms

Improving patient diagnostics for clinicians and laboratories

Conducting comprehensive scientific literature reviews for researchers

Validating scientific hypotheses with evidence-based insights

Not Ideal For

Individuals or small businesses outside of the healthcare and life sciences sectors.

General-purpose AI research not focused on biology or medicine.

Organizations seeking low-cost or self-service AI solutions.

Use cases outside of drug discovery, development, or diagnostics.

Frequently Asked Questions

Your Actions

Dimension Scores

Ease of Use4/10

Output Quality8/10

Value for Money6/10

Customization6/10

Support7/10

Integration6/10

Task Scores

Research Analysis

Diagnosis Support

Compliance Tracking

Clinical Documentation

Patient Communication

Drug Interaction Check

Health Monitoring

Appointment Management

Trust Score

44/100

Limited Data

Based on 6 data signals

Reflects publicly available data, not an independent audit

Social Proof10/40

Customers (per vendor website)Sanofi, BMS, MSD

Company Strength25/25

Team Size201-500

Funding$334M

Company ListedOwkin

Operational Trust4/20

Data ResidencyMultiple regions

Compliance5/15

GDPR (as claimed)Yes

Switching & Migration

Migration Difficulty

Significant Effort

Data portable as:

API

Email only (dpo@owkin.com)

API Access